Private Equity
Mercato Partners has set out to raise a $250 million venture-capital fund, according to a filing with the SEC.
1 min read · 01 October 2018
Remedy Review, a newly launched digital publishing company focused on covering the hemp, cannabinoids, and natural health space, has raised $2 million in funding. The investor is One Better Ventures. Remedy Review will operate out of Three Ships, a Raleigh, North Carolina-based digital publisher and customer acquisition company.
3 min read · 01 October 2018
Hologic has agreed to acquire Sunnyvale, California-based Focal Therapeutics, a medical device company, for $125 million. Focal Therapeutics was backed by Okapi Venture Capital and Emergent Medical Partners, according to Crunchbase.
3 min read · 01 October 2018
Town Hall Ventures has raised $115 million for its new fund, according to an SEC filing. Based in New York City, the firm invests in healthcare solutions for underserved communities.
1 min read · 01 October 2018
VelosBio, a biotech firm focused on oncology, has raised $58 million in Series A funding. Arix Bioscience plc and Sofinnova Ventures led the round with participation from other other investors that included Pappas Ventures, Chiesi Ventures, Takeda Ventures Inc and Decheng Capital. In conjunction with the funding, Mark Chin, Arix investment director, will join the VelosBio board of directors.
1 min read · 01 October 2018
Oakland, California-based Modis Therapeutics, a developer of medicines for patients with rare genetic diseases, has raised $30 million in Series A funding. F-Prime Capital Partners and OrbiMed led the round.
1 min read · 01 October 2018
FirePower Capital has entered into a $100 million joint venture that will expand its debt-financing horizon, according to a news release. The Toronto firm said Friday it formed a JV with Arena Investors, a New York investor and merchant-capital provider. The partnership will enable FirePower to increase credit available to Canadian mid-market companies to a range of $1 million to $20 million. FirePower, which offers first-lien, unitranche, second-lien, mezzanine and venture loans through its Gap Debt fund, is especially active in Canadian technology sectors.
2 min read · 01 October 2018
2 min read · 28 September 2018
Sequoia Capital formally filed to raise new U.S. venture-capital and growth funds, according a several of documents submitted to the SEC. The Silicon Valley firm did not report targets for the funds or initial closings.
1 min read · 28 September 2018
Emeryville, California-based Gritstone Oncology Inc, a developer of tumor-specific cancer immunotherapies, has raised about $100 million after pricing its IPO of over 6.6 million shares at $15 per share. The stock began trading September 28, 2018 on the NASDAQ under the ticker symbol "GRTS." Goldman Sachs, Cowen and Company LLC and Barclays Capital Inc are the lead underwriters. Gritstone Oncology’s pre-IPO backers included Versant Ventures, The Column Group, Clarus Funds, Frazier Healthcare Partners, RedMile, Casdin Capital, Lilly Asia Ventures, Trinitas Capital, GV, Alexandria Venture Investments and Bay City Capital.
3 min read · 28 September 2018
